Flugantia is an innovative start-up established in 2018 as a joint-stock company with a focus on Socially Responsible Investing (SRI). The company acquires embryonic technologies from research, applies its unique production process to develop them up to TRL7 level, and presents them to the industry as smart intellectual property. Flugantia's production process "Agile Research Framework" follows the time-resource equation and the "build-measure-learn" cycle of the Lean methodology. The company is committed to building a network of companies and researchers according to its Industrial Plan, with collaborations already underway with various institutions.